Viloxazine: A review of the literature
Publication
, Journal Article
Ban, TA; McEvoy, JP; Wilson, WH
Published in: International Pharmacopsychiatry
1980
In animal pharmacological studies viloxazine has shown similarities to imipramine. The antidepressant effects of the substance were independently recognized in seven uncontrolled clinical trials and verified in 11 published standard controlled clinical studies in which viloxazine in the dosage range from 150- to 300-mg dosage was equal in overall therapeutic efficacy to imipramine and amitriptyline, but produced a lower incidence of side effects.
Duke Scholars
Published In
International Pharmacopsychiatry
Publication Date
1980
Volume
15
Issue
2
Start / End Page
118 / 123
Related Subject Headings
- Psychiatry
- 1702 Cognitive Sciences
- 1109 Neurosciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Ban, T. A., McEvoy, J. P., & Wilson, W. H. (1980). Viloxazine: A review of the literature. International Pharmacopsychiatry, 15(2), 118–123.
Ban, T. A., J. P. McEvoy, and W. H. Wilson. “Viloxazine: A review of the literature.” International Pharmacopsychiatry 15, no. 2 (1980): 118–23.
Ban TA, McEvoy JP, Wilson WH. Viloxazine: A review of the literature. International Pharmacopsychiatry. 1980;15(2):118–23.
Ban, T. A., et al. “Viloxazine: A review of the literature.” International Pharmacopsychiatry, vol. 15, no. 2, 1980, pp. 118–23.
Ban TA, McEvoy JP, Wilson WH. Viloxazine: A review of the literature. International Pharmacopsychiatry. 1980;15(2):118–123.
Published In
International Pharmacopsychiatry
Publication Date
1980
Volume
15
Issue
2
Start / End Page
118 / 123
Related Subject Headings
- Psychiatry
- 1702 Cognitive Sciences
- 1109 Neurosciences
- 1103 Clinical Sciences